Benzinga | Jan 7, 2022 01:04PM EST

Credit Suisse Downgrades eHealth to Neutral, Lowers Price Target to $31

Credit Suisse analyst Jailendra Singh downgrades eHealth (NASDAQ:EHTH) from Outperform to Neutral and lowers the price target from $45 to $31.